OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Rating of “Moderate Buy” from Analysts

OrthoPediatrics Corp. (NASDAQ:KIDS) has been assigned an average rating of “Moderate Buy” from the eleven research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $25.8889.

Several equities analysts have issued reports on the stock. Canaccord Genuity Group set a $25.00 price objective on shares of OrthoPediatrics in a research note on Friday, April 24th. Piper Sandler reiterated an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. BTIG Research reissued a “buy” rating and issued a $24.00 target price on shares of OrthoPediatrics in a research report on Friday, May 1st. Finally, Weiss Ratings upgraded OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday.

Institutional Investors Weigh In On OrthoPediatrics

Several large investors have recently modified their holdings of KIDS. BlackRock Inc. purchased a new stake in OrthoPediatrics in the 2nd quarter valued at $24,347,000. Deutsche Bank AG purchased a new stake in shares of OrthoPediatrics in the second quarter valued at about $303,000. AIGH Capital Management LLC purchased a new stake in shares of OrthoPediatrics in the second quarter valued at about $5,161,000. Bank of New York Mellon Corp acquired a new stake in shares of OrthoPediatrics during the second quarter worth about $992,000. Finally, Wasatch Advisors LP boosted its stake in shares of OrthoPediatrics by 56.6% during the second quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after buying an additional 186,357 shares during the period. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Price Performance

KIDS stock opened at $22.77 on Friday. The business has a 50 day moving average price of $19.39 and a 200 day moving average price of $17.91. The stock has a market cap of $594.52 million, a price-to-earnings ratio of -13.55 and a beta of 0.98. OrthoPediatrics has a fifty-two week low of $14.42 and a fifty-two week high of $23.17. The company has a quick ratio of 2.37, a current ratio of 4.78 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analysts’ expectations of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. Equities research analysts anticipate that OrthoPediatrics will post -1.14 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.